ESC Professional Premium Access

Frequent need for apixaban dose adjustment for atrial fibrillation in an unselected acute medical admission population during the COVID 19 pandemic.

Congress Presentation

About the speaker

Doctor Khin Kay Kay Kyaw

New Cross Hospital, Wolverhampton (United Kingdom of Great Britain & Northern Ireland)
2 presentations
1 follower

27 more presentations in this session

The use of hatch score for the prediction of post operative atrial fibrillation (poaf) after coronary artery bypass graft: a meta-analysis

Speaker: Doctor A. Ramos (Muntinlupa, PH)

Thumbnail

Relationship and outcomes between volume status, cardiac and renal dysfunction in patients with chronic heart failure.

Speaker: Doctor A. Challa (Rochester, US)

Thumbnail

Association between triglyceride and all-cause mortality and cardiovascular outcomes in heart failure patients: a territory-wide study in Hong Kong

Speaker: Mrs Q. Ren (Hong Kong, HK)

Thumbnail

Effects of SGLT2 inhibitors on heart failure symptoms, quality of life and exercise capacity in patients with heart failure and preserved ejection fraction: A meta-analysis

Speaker: Doctor L. Merin (Cebu City, PH)

Thumbnail

Incident heart failure and the subsequent risk for progression to end stage kidney disease in South East Asian people with type 2 diabetes

Speaker: Ms S. L (Singapore, SG)

Thumbnail

Access the full session

Poster Session 1

Speakers: Doctor K. Kyaw, Doctor A. Ramos, Doctor A. Challa, Mrs Q. Ren, Doctor L. Merin...
Thumbnail

About the event

Image

ESC Asia 2022 with APSC & AFC

1 December - 3 December 2022

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk